Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury

M. Chudickova, I. Vackova, L. Machova Urdzikova, P. Jancova, K. Kekulova, M. Rehorova, K. Turnovcova, P. Jendelova, S. Kubinova,

. 2019 ; 20 (18) : . [pub] 20190912

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005871

Grantová podpora
17-03765S Grantová Agentura České Republiky
CZ.02.1.01/0.0./0.0/15_003/0000419 Ministerstvo Školství, Mládeže a Tělovýchovy

The transplantation of Wharton's jelly derived mesenchymal stromal cells (WJ-MSCs) possesses therapeutic potential for the treatment of a spinal cord injury (SCI). Generally, the main effect of MSCs is mediated by their paracrine potential. Therefore, application of WJ-MSC derived conditioned media (CM) is an acknowledged approach for how to bypass the limited survival of transplanted cells. In this study, we compared the effect of human WJ-MSCs and their CM in the treatment of SCI in rats. WJ-MSCs and their CM were intrathecally transplanted in the three consecutive weeks following the induction of a balloon compression lesion. Behavioral analyses were carried out up to 9 weeks after the SCI and revealed significant improvement after the treatment with WJ-MSCs and CM, compared to the saline control. Both WJ-MSCs and CM treatment resulted in a higher amount of spared gray and white matter and enhanced expression of genes related to axonal growth. However, only the CM treatment further improved axonal sprouting and reduced the number of reactive astrocytes in the lesion area. On the other hand, WJ-MSCs enhanced the expression of inflammatory and chemotactic markers in plasma, which indicates a systemic immunological response to xenogeneic cell transplantation. Our results confirmed that WJ-MSC derived CM offer an alternative to direct stem cell transplantation for the treatment of SCI.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005871
003      
CZ-PrNML
005      
20240703135245.0
007      
ta
008      
200511s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms20184516 $2 doi
035    __
$a (PubMed)31547264
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Chudickova, Milada $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. milada.chudickova@iem.cas.cz.
245    14
$a The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury / $c M. Chudickova, I. Vackova, L. Machova Urdzikova, P. Jancova, K. Kekulova, M. Rehorova, K. Turnovcova, P. Jendelova, S. Kubinova,
520    9_
$a The transplantation of Wharton's jelly derived mesenchymal stromal cells (WJ-MSCs) possesses therapeutic potential for the treatment of a spinal cord injury (SCI). Generally, the main effect of MSCs is mediated by their paracrine potential. Therefore, application of WJ-MSC derived conditioned media (CM) is an acknowledged approach for how to bypass the limited survival of transplanted cells. In this study, we compared the effect of human WJ-MSCs and their CM in the treatment of SCI in rats. WJ-MSCs and their CM were intrathecally transplanted in the three consecutive weeks following the induction of a balloon compression lesion. Behavioral analyses were carried out up to 9 weeks after the SCI and revealed significant improvement after the treatment with WJ-MSCs and CM, compared to the saline control. Both WJ-MSCs and CM treatment resulted in a higher amount of spared gray and white matter and enhanced expression of genes related to axonal growth. However, only the CM treatment further improved axonal sprouting and reduced the number of reactive astrocytes in the lesion area. On the other hand, WJ-MSCs enhanced the expression of inflammatory and chemotactic markers in plasma, which indicates a systemic immunological response to xenogeneic cell transplantation. Our results confirmed that WJ-MSC derived CM offer an alternative to direct stem cell transplantation for the treatment of SCI.
650    _2
$a zvířata $7 D000818
650    _2
$a kultivované buňky $7 D002478
650    _2
$a kultivační média speciální $x farmakologie $7 D017077
650    _2
$a cytokiny $x krev $7 D016207
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a transplantace mezenchymálních kmenových buněk $x metody $7 D045164
650    _2
$a mezenchymální kmenové buňky $x cytologie $7 D059630
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a poranění míchy $x krev $x patofyziologie $x terapie $7 D013119
650    _2
$a Whartonův rosol $x cytologie $7 D059631
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vackova, Irena $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. irena.vackova@iem.cas.cz.
700    1_
$a Machová Urdzíková, Lucia $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. lucia.machova@iem.cas.cz. $7 xx0136406
700    1_
$a Jancova, Pavlina $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. jancova.paja@seznam.cz.
700    1_
$a Kekulova, Kristyna $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. kristyna.kekulova@iem.cas.cz.
700    1_
$a Rehorova, Monika $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. monika.seneklova@iem.cas.cz. Charles University, Second Faculty of Medicine, 14220 Prague, Czech Republic. monika.seneklova@iem.cas.cz.
700    1_
$a Turnovcova, Karolina $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. karolina.turnovcova@iem.cas.cz.
700    1_
$a Jendelova, Pavla $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. pavla.jendelova@iem.cas.cz.
700    1_
$a Kubinova, Sarka $u Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14200 Prague, Czech Republic. sarka.kubinova@iem.cas.cz.
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 20, č. 18 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31547264 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20240703135240 $b ABA008
999    __
$a ok $b bmc $g 1524729 $s 1095927
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 18 $e 20190912 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 17-03765S $p Grantová Agentura České Republiky
GRA    __
$a CZ.02.1.01/0.0./0.0/15_003/0000419 $p Ministerstvo Školství, Mládeže a Tělovýchovy
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...